(MedPage Today) — A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing VISIONARY study.
In the first 320 trial participants randomized in the phase III study, those treated with…
Source link : https://www.medpagetoday.com/meetingcoverage/era/115954
Author :
Publish date : 2025-06-07 18:56:00
Copyright for syndicated content belongs to the linked Source.
